nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosaprepitant—Glycosuria—Entecavir—hepatitis B	0.0264	0.0264	CcSEcCtD
Fosaprepitant—Glycosuria—Adefovir Dipivoxil—hepatitis B	0.0258	0.0258	CcSEcCtD
Fosaprepitant—Chest discomfort—Telbivudine—hepatitis B	0.0199	0.0199	CcSEcCtD
Fosaprepitant—Abdominal pain upper—Entecavir—hepatitis B	0.0142	0.0142	CcSEcCtD
Fosaprepitant—Alanine aminotransferase increased—Adefovir Dipivoxil—hepatitis B	0.0134	0.0134	CcSEcCtD
Fosaprepitant—Weight decreased—Adefovir Dipivoxil—hepatitis B	0.0119	0.0119	CcSEcCtD
Fosaprepitant—Abdominal pain upper—Telbivudine—hepatitis B	0.0117	0.0117	CcSEcCtD
Fosaprepitant—Aspartate aminotransferase increased—Telbivudine—hepatitis B	0.0115	0.0115	CcSEcCtD
Fosaprepitant—Haematuria—Entecavir—hepatitis B	0.0114	0.0114	CcSEcCtD
Fosaprepitant—Muscular weakness—Telbivudine—hepatitis B	0.0113	0.0113	CcSEcCtD
Fosaprepitant—Alanine aminotransferase increased—Telbivudine—hepatitis B	0.0113	0.0113	CcSEcCtD
Fosaprepitant—Haematuria—Adefovir Dipivoxil—hepatitis B	0.0111	0.0111	CcSEcCtD
Fosaprepitant—Abdominal distension—Telbivudine—hepatitis B	0.0111	0.0111	CcSEcCtD
Fosaprepitant—Oropharyngeal pain—Lamivudine—hepatitis B	0.0109	0.0109	CcSEcCtD
Fosaprepitant—Abdominal discomfort—Telbivudine—hepatitis B	0.0106	0.0106	CcSEcCtD
Fosaprepitant—Urinary tract disorder—Adefovir Dipivoxil—hepatitis B	0.0104	0.0104	CcSEcCtD
Fosaprepitant—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.0103	0.0103	CcSEcCtD
Fosaprepitant—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.0103	0.0103	CcSEcCtD
Fosaprepitant—Eructation—Lamivudine—hepatitis B	0.00974	0.00974	CcSEcCtD
Fosaprepitant—Immune system disorder—Entecavir—hepatitis B	0.00971	0.00971	CcSEcCtD
Fosaprepitant—Wheezing—Lamivudine—hepatitis B	0.00963	0.00963	CcSEcCtD
Fosaprepitant—Mental disorder—Entecavir—hepatitis B	0.00942	0.00942	CcSEcCtD
Fosaprepitant—Malnutrition—Entecavir—hepatitis B	0.00936	0.00936	CcSEcCtD
Fosaprepitant—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.00913	0.00913	CcSEcCtD
Fosaprepitant—Flatulence—Adefovir Dipivoxil—hepatitis B	0.009	0.009	CcSEcCtD
Fosaprepitant—Urine output increased—Lamivudine—hepatitis B	0.00896	0.00896	CcSEcCtD
Fosaprepitant—Hypoaesthesia—Telbivudine—hepatitis B	0.00879	0.00879	CcSEcCtD
Fosaprepitant—Connective tissue disorder—Telbivudine—hepatitis B	0.00868	0.00868	CcSEcCtD
Fosaprepitant—Anaemia—Adefovir Dipivoxil—hepatitis B	0.00844	0.00844	CcSEcCtD
Fosaprepitant—Cough—Adefovir Dipivoxil—hepatitis B	0.00797	0.00797	CcSEcCtD
Fosaprepitant—Mediastinal disorder—Telbivudine—hepatitis B	0.00796	0.00796	CcSEcCtD
Fosaprepitant—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00791	0.00791	CcSEcCtD
Fosaprepitant—Chest pain—Adefovir Dipivoxil—hepatitis B	0.00778	0.00778	CcSEcCtD
Fosaprepitant—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00772	0.00772	CcSEcCtD
Fosaprepitant—Malnutrition—Telbivudine—hepatitis B	0.00769	0.00769	CcSEcCtD
Fosaprepitant—Anaphylactic shock—Entecavir—hepatitis B	0.00764	0.00764	CcSEcCtD
Fosaprepitant—Infection—Entecavir—hepatitis B	0.00759	0.00759	CcSEcCtD
Fosaprepitant—Dysgeusia—Telbivudine—hepatitis B	0.00753	0.00753	CcSEcCtD
Fosaprepitant—Nervous system disorder—Entecavir—hepatitis B	0.00749	0.00749	CcSEcCtD
Fosaprepitant—Skin disorder—Entecavir—hepatitis B	0.00742	0.00742	CcSEcCtD
Fosaprepitant—Muscle spasms—Telbivudine—hepatitis B	0.00739	0.00739	CcSEcCtD
Fosaprepitant—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.00731	0.00731	CcSEcCtD
Fosaprepitant—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00724	0.00724	CcSEcCtD
Fosaprepitant—Ill-defined disorder—Telbivudine—hepatitis B	0.00713	0.00713	CcSEcCtD
Fosaprepitant—Malaise—Telbivudine—hepatitis B	0.00693	0.00693	CcSEcCtD
Fosaprepitant—Insomnia—Entecavir—hepatitis B	0.00691	0.00691	CcSEcCtD
Fosaprepitant—Somnolence—Entecavir—hepatitis B	0.00679	0.00679	CcSEcCtD
Fosaprepitant—Dyspepsia—Entecavir—hepatitis B	0.00672	0.00672	CcSEcCtD
Fosaprepitant—Cough—Telbivudine—hepatitis B	0.00671	0.00671	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Entecavir—hepatitis B	0.0066	0.0066	CcSEcCtD
Fosaprepitant—Fatigue—Entecavir—hepatitis B	0.00659	0.00659	CcSEcCtD
Fosaprepitant—Abdominal pain upper—Lamivudine—hepatitis B	0.00657	0.00657	CcSEcCtD
Fosaprepitant—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.00656	0.00656	CcSEcCtD
Fosaprepitant—Chest pain—Telbivudine—hepatitis B	0.00655	0.00655	CcSEcCtD
Fosaprepitant—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.0065	0.0065	CcSEcCtD
Fosaprepitant—Aspartate aminotransferase increased—Lamivudine—hepatitis B	0.00648	0.00648	CcSEcCtD
Fosaprepitant—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.00648	0.00648	CcSEcCtD
Fosaprepitant—Discomfort—Telbivudine—hepatitis B	0.00647	0.00647	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00643	0.00643	CcSEcCtD
Fosaprepitant—Alanine aminotransferase increased—Lamivudine—hepatitis B	0.00635	0.00635	CcSEcCtD
Fosaprepitant—Muscular weakness—Lamivudine—hepatitis B	0.00635	0.00635	CcSEcCtD
Fosaprepitant—Abdominal distension—Lamivudine—hepatitis B	0.00626	0.00626	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Entecavir—hepatitis B	0.00625	0.00625	CcSEcCtD
Fosaprepitant—Nervous system disorder—Telbivudine—hepatitis B	0.00615	0.00615	CcSEcCtD
Fosaprepitant—Skin disorder—Telbivudine—hepatitis B	0.0061	0.0061	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.00609	0.00609	CcSEcCtD
Fosaprepitant—Abdominal pain—Entecavir—hepatitis B	0.00604	0.00604	CcSEcCtD
Fosaprepitant—Body temperature increased—Entecavir—hepatitis B	0.00604	0.00604	CcSEcCtD
Fosaprepitant—Abdominal discomfort—Lamivudine—hepatitis B	0.00596	0.00596	CcSEcCtD
Fosaprepitant—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.00589	0.00589	CcSEcCtD
Fosaprepitant—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.00589	0.00589	CcSEcCtD
Fosaprepitant—Dysuria—Lamivudine—hepatitis B	0.00582	0.00582	CcSEcCtD
Fosaprepitant—Pollakiuria—Lamivudine—hepatitis B	0.00575	0.00575	CcSEcCtD
Fosaprepitant—Insomnia—Telbivudine—hepatitis B	0.00568	0.00568	CcSEcCtD
Fosaprepitant—Dyspepsia—Telbivudine—hepatitis B	0.00552	0.00552	CcSEcCtD
Fosaprepitant—Stevens-Johnson syndrome—Lamivudine—hepatitis B	0.0055	0.0055	CcSEcCtD
Fosaprepitant—Asthenia—Entecavir—hepatitis B	0.00548	0.00548	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00542	0.00542	CcSEcCtD
Fosaprepitant—Fatigue—Telbivudine—hepatitis B	0.00541	0.00541	CcSEcCtD
Fosaprepitant—Stomatitis—Lamivudine—hepatitis B	0.00541	0.00541	CcSEcCtD
Fosaprepitant—Pain—Telbivudine—hepatitis B	0.00537	0.00537	CcSEcCtD
Fosaprepitant—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00535	0.00535	CcSEcCtD
Fosaprepitant—Pruritus—Adefovir Dipivoxil—hepatitis B	0.00527	0.00527	CcSEcCtD
Fosaprepitant—Diarrhoea—Entecavir—hepatitis B	0.00523	0.00523	CcSEcCtD
Fosaprepitant—Feeling abnormal—Telbivudine—hepatitis B	0.00517	0.00517	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Telbivudine—hepatitis B	0.00513	0.00513	CcSEcCtD
Fosaprepitant—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.0051	0.0051	CcSEcCtD
Fosaprepitant—Dizziness—Entecavir—hepatitis B	0.00505	0.00505	CcSEcCtD
Fosaprepitant—Abdominal pain—Telbivudine—hepatitis B	0.00496	0.00496	CcSEcCtD
Fosaprepitant—Body temperature increased—Telbivudine—hepatitis B	0.00496	0.00496	CcSEcCtD
Fosaprepitant—Hypoaesthesia—Lamivudine—hepatitis B	0.00495	0.00495	CcSEcCtD
Fosaprepitant—Connective tissue disorder—Lamivudine—hepatitis B	0.00489	0.00489	CcSEcCtD
Fosaprepitant—Vomiting—Entecavir—hepatitis B	0.00486	0.00486	CcSEcCtD
Fosaprepitant—Rash—Entecavir—hepatitis B	0.00482	0.00482	CcSEcCtD
Fosaprepitant—Dermatitis—Entecavir—hepatitis B	0.00481	0.00481	CcSEcCtD
Fosaprepitant—Headache—Entecavir—hepatitis B	0.00479	0.00479	CcSEcCtD
Fosaprepitant—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00474	0.00474	CcSEcCtD
Fosaprepitant—Erythema multiforme—Lamivudine—hepatitis B	0.00471	0.00471	CcSEcCtD
Fosaprepitant—Rash—Adefovir Dipivoxil—hepatitis B	0.0047	0.0047	CcSEcCtD
Fosaprepitant—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.0047	0.0047	CcSEcCtD
Fosaprepitant—Headache—Adefovir Dipivoxil—hepatitis B	0.00467	0.00467	CcSEcCtD
Fosaprepitant—Nausea—Entecavir—hepatitis B	0.00454	0.00454	CcSEcCtD
Fosaprepitant—Asthenia—Telbivudine—hepatitis B	0.0045	0.0045	CcSEcCtD
Fosaprepitant—Immune system disorder—Lamivudine—hepatitis B	0.0045	0.0045	CcSEcCtD
Fosaprepitant—Mediastinal disorder—Lamivudine—hepatitis B	0.00449	0.00449	CcSEcCtD
Fosaprepitant—Pruritus—Telbivudine—hepatitis B	0.00444	0.00444	CcSEcCtD
Fosaprepitant—Nausea—Adefovir Dipivoxil—hepatitis B	0.00443	0.00443	CcSEcCtD
Fosaprepitant—Erythema—Lamivudine—hepatitis B	0.00433	0.00433	CcSEcCtD
Fosaprepitant—Malnutrition—Lamivudine—hepatitis B	0.00433	0.00433	CcSEcCtD
Fosaprepitant—Diarrhoea—Telbivudine—hepatitis B	0.00429	0.00429	CcSEcCtD
Fosaprepitant—Flatulence—Lamivudine—hepatitis B	0.00427	0.00427	CcSEcCtD
Fosaprepitant—Dysgeusia—Lamivudine—hepatitis B	0.00424	0.00424	CcSEcCtD
Fosaprepitant—Muscle spasms—Lamivudine—hepatitis B	0.00417	0.00417	CcSEcCtD
Fosaprepitant—Dizziness—Telbivudine—hepatitis B	0.00415	0.00415	CcSEcCtD
Fosaprepitant—Ill-defined disorder—Lamivudine—hepatitis B	0.00402	0.00402	CcSEcCtD
Fosaprepitant—Anaemia—Lamivudine—hepatitis B	0.00401	0.00401	CcSEcCtD
Fosaprepitant—Vomiting—Telbivudine—hepatitis B	0.00399	0.00399	CcSEcCtD
Fosaprepitant—Angioedema—Lamivudine—hepatitis B	0.00396	0.00396	CcSEcCtD
Fosaprepitant—Rash—Telbivudine—hepatitis B	0.00396	0.00396	CcSEcCtD
Fosaprepitant—Dermatitis—Telbivudine—hepatitis B	0.00395	0.00395	CcSEcCtD
Fosaprepitant—Headache—Telbivudine—hepatitis B	0.00393	0.00393	CcSEcCtD
Fosaprepitant—Malaise—Lamivudine—hepatitis B	0.00391	0.00391	CcSEcCtD
Fosaprepitant—Syncope—Lamivudine—hepatitis B	0.00389	0.00389	CcSEcCtD
Fosaprepitant—Loss of consciousness—Lamivudine—hepatitis B	0.00381	0.00381	CcSEcCtD
Fosaprepitant—Cough—Lamivudine—hepatitis B	0.00378	0.00378	CcSEcCtD
Fosaprepitant—Nausea—Telbivudine—hepatitis B	0.00373	0.00373	CcSEcCtD
Fosaprepitant—Chest pain—Lamivudine—hepatitis B	0.00369	0.00369	CcSEcCtD
Fosaprepitant—Anxiety—Lamivudine—hepatitis B	0.00368	0.00368	CcSEcCtD
Fosaprepitant—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.00366	0.00366	CcSEcCtD
Fosaprepitant—Discomfort—Lamivudine—hepatitis B	0.00365	0.00365	CcSEcCtD
Fosaprepitant—Dry mouth—Lamivudine—hepatitis B	0.00361	0.00361	CcSEcCtD
Fosaprepitant—Anaphylactic shock—Lamivudine—hepatitis B	0.00354	0.00354	CcSEcCtD
Fosaprepitant—Oedema—Lamivudine—hepatitis B	0.00354	0.00354	CcSEcCtD
Fosaprepitant—Infection—Lamivudine—hepatitis B	0.00351	0.00351	CcSEcCtD
Fosaprepitant—Shock—Lamivudine—hepatitis B	0.00348	0.00348	CcSEcCtD
Fosaprepitant—Nervous system disorder—Lamivudine—hepatitis B	0.00347	0.00347	CcSEcCtD
Fosaprepitant—Skin disorder—Lamivudine—hepatitis B	0.00344	0.00344	CcSEcCtD
Fosaprepitant—Hyperhidrosis—Lamivudine—hepatitis B	0.00342	0.00342	CcSEcCtD
Fosaprepitant—Hypotension—Lamivudine—hepatitis B	0.0033	0.0033	CcSEcCtD
Fosaprepitant—Insomnia—Lamivudine—hepatitis B	0.0032	0.0032	CcSEcCtD
Fosaprepitant—Dyspnoea—Lamivudine—hepatitis B	0.00315	0.00315	CcSEcCtD
Fosaprepitant—Somnolence—Lamivudine—hepatitis B	0.00314	0.00314	CcSEcCtD
Fosaprepitant—Dyspepsia—Lamivudine—hepatitis B	0.00311	0.00311	CcSEcCtD
Fosaprepitant—Decreased appetite—Lamivudine—hepatitis B	0.00307	0.00307	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Lamivudine—hepatitis B	0.00305	0.00305	CcSEcCtD
Fosaprepitant—Fatigue—Lamivudine—hepatitis B	0.00305	0.00305	CcSEcCtD
Fosaprepitant—Pain—Lamivudine—hepatitis B	0.00302	0.00302	CcSEcCtD
Fosaprepitant—Constipation—Lamivudine—hepatitis B	0.00302	0.00302	CcSEcCtD
Fosaprepitant—Feeling abnormal—Lamivudine—hepatitis B	0.00291	0.00291	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Lamivudine—hepatitis B	0.00289	0.00289	CcSEcCtD
Fosaprepitant—Urticaria—Lamivudine—hepatitis B	0.00281	0.00281	CcSEcCtD
Fosaprepitant—Abdominal pain—Lamivudine—hepatitis B	0.0028	0.0028	CcSEcCtD
Fosaprepitant—Body temperature increased—Lamivudine—hepatitis B	0.0028	0.0028	CcSEcCtD
Fosaprepitant—Hypersensitivity—Lamivudine—hepatitis B	0.00261	0.00261	CcSEcCtD
Fosaprepitant—Asthenia—Lamivudine—hepatitis B	0.00254	0.00254	CcSEcCtD
Fosaprepitant—Pruritus—Lamivudine—hepatitis B	0.0025	0.0025	CcSEcCtD
Fosaprepitant—Diarrhoea—Lamivudine—hepatitis B	0.00242	0.00242	CcSEcCtD
Fosaprepitant—Dizziness—Lamivudine—hepatitis B	0.00234	0.00234	CcSEcCtD
Fosaprepitant—Vomiting—Lamivudine—hepatitis B	0.00225	0.00225	CcSEcCtD
Fosaprepitant—Rash—Lamivudine—hepatitis B	0.00223	0.00223	CcSEcCtD
Fosaprepitant—Dermatitis—Lamivudine—hepatitis B	0.00223	0.00223	CcSEcCtD
Fosaprepitant—Headache—Lamivudine—hepatitis B	0.00222	0.00222	CcSEcCtD
Fosaprepitant—Nausea—Lamivudine—hepatitis B	0.0021	0.0021	CcSEcCtD
